Drug Approval | October 21, 2021
U.S. FDA gives green light to Moderna and J&J booster doses
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses
New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
The vaccine was 85 percent effective in preventing severe disease across all regions.
Subscribe To Our Newsletter & Stay Updated
